Alzamend Common Stock from 2010 to 2025

ALZN Stock  USD 0.68  0.01  1.45%   
Alzamend Neuro Common Stock yearly trend continues to be very stable with very little volatility. Common Stock is likely to drop to 75.38. During the period from 2010 to 2025, Alzamend Neuro Common Stock quarterly data regression pattern had sample variance of 8.8 M and median of  3,287. View All Fundamentals
 
Common Stock  
First Reported
2019-04-30
Previous Quarter
523
Current Value
580
Quarterly Volatility
3.8 K
 
Covid
Check Alzamend Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alzamend Neuro's main balance sheet or income statement drivers, such as Interest Expense of 11 K, Interest Income of 0.0 or Depreciation And Amortization of 43.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Alzamend financial statements analysis is a perfect complement when working with Alzamend Neuro Valuation or Volatility modules.
  
Check out the analysis of Alzamend Neuro Correlation against competitors.
To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.

Latest Alzamend Neuro's Common Stock Growth Pattern

Below is the plot of the Common Stock of Alzamend Neuro over the last few years. It is Alzamend Neuro's Common Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alzamend Neuro's overall financial position and show how it may be relating to other accounts over time.
Common Stock10 Years Trend
Very volatile
   Common Stock   
       Timeline  

Alzamend Common Stock Regression Statistics

Arithmetic Mean4,177
Geometric Mean2,152
Coefficient Of Variation70.97
Mean Deviation2,317
Median3,287
Standard Deviation2,965
Sample Variance8.8M
Range9.6K
R-Value0.01
Mean Square Error9.4M
R-Squared0.0001
Significance0.97
Slope6.33
Total Sum of Squares131.8M

Alzamend Common Stock History

2025 75.38
2024 79.35
2023 69.0
2022 9694.0
2021 9548.0
2020 6743.0
2019 6476.0

Other Fundumenentals of Alzamend Neuro

Alzamend Neuro Common Stock component correlations

-0.550.42-0.01-0.170.90.390.850.72-0.69-0.890.230.740.090.710.660.62-0.53-0.26
-0.55-0.960.210.55-0.280.15-0.190.070.890.28-0.850.040.530.09-0.85-0.950.880.91
0.42-0.96-0.14-0.670.14-0.230.04-0.22-0.77-0.130.85-0.19-0.6-0.240.720.91-0.92-0.96
-0.010.21-0.140.140.040.25-0.11-0.040.30.14-0.21-0.050.11-0.04-0.29-0.260.240.22
-0.170.55-0.670.140.140.510.20.370.39-0.13-0.380.350.690.39-0.3-0.50.840.71
0.9-0.280.140.040.140.730.980.92-0.51-0.98-0.030.930.50.920.490.37-0.210.04
0.390.15-0.230.250.510.730.710.78-0.1-0.66-0.350.780.880.790.11-0.130.310.4
0.85-0.190.04-0.110.20.980.710.96-0.43-0.99-0.10.970.560.960.410.3-0.150.13
0.720.07-0.22-0.040.370.920.780.96-0.22-0.93-0.341.00.721.00.210.040.110.38
-0.690.89-0.770.30.39-0.51-0.1-0.43-0.220.51-0.63-0.250.27-0.2-0.98-0.830.740.7
-0.890.28-0.130.14-0.13-0.98-0.66-0.99-0.930.510.01-0.94-0.49-0.92-0.49-0.40.24-0.03
0.23-0.850.85-0.21-0.38-0.03-0.35-0.1-0.34-0.630.01-0.32-0.59-0.350.660.88-0.72-0.9
0.740.04-0.19-0.050.350.930.780.971.0-0.25-0.94-0.320.71.00.250.070.080.36
0.090.53-0.60.110.690.50.880.560.720.27-0.49-0.590.70.73-0.25-0.450.610.69
0.710.09-0.24-0.040.390.920.790.961.0-0.2-0.92-0.351.00.730.20.020.130.4
0.66-0.850.72-0.29-0.30.490.110.410.21-0.98-0.490.660.25-0.250.20.82-0.68-0.66
0.62-0.950.91-0.26-0.50.37-0.130.30.04-0.83-0.40.880.07-0.450.020.82-0.89-0.88
-0.530.88-0.920.240.84-0.210.31-0.150.110.740.24-0.720.080.610.13-0.68-0.890.91
-0.260.91-0.960.220.710.040.40.130.380.7-0.03-0.90.360.690.4-0.66-0.880.91
Click cells to compare fundamentals

About Alzamend Neuro Financial Statements

Alzamend Neuro investors utilize fundamental indicators, such as Common Stock, to predict how Alzamend Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Common Stock 79.35  75.38 
Common Stock Total Equity11.1 K8.5 K
Common Stock Shares Outstanding608.9 K578.5 K
When determining whether Alzamend Neuro offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alzamend Neuro's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alzamend Neuro Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alzamend Neuro Stock:
Check out the analysis of Alzamend Neuro Correlation against competitors.
To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(134.51)
Return On Assets
(1.22)
Return On Equity
(10.93)
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.